Navigation Links
GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
Date:9/10/2008

Kinobeads(TM) Technology to Identify a New Generation of Drug Candidates

for Inflammatory Diseases

LONDON and CAMBRIDGE, England and PHILADELPHIA and HEIDELBERG, Germany, September 10 /PRNewswire/ -- Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.

The alliance gives GSK access to Cellzome's significant expertise in identifying and developing selective kinase inhibitors and its proprietary Kinobeads(TM) technology which, by screening compounds in a physiological setting, is designed to improve the predictability of these drug candidates' performance in clinical testing. Kinases are key molecular switches in cellular signaling events with a central role in many inflammatory responses and selective inhibitors offer a different approach to therapeutic intervention in diseases such as rheumatoid arthritis or multiple sclerosis.

Under the agreement GSK has exclusive options to license drug candidates from Cellzome's kinase programs directed against four identified targets, and three additional targets to be jointly identified by both parties. In the alliance, Cellzome will utilize its proprietary Kinobeads(TM) technology to discover novel small molecule inhibitors of these targets, and then will develop the most promising product candidates through to completion of a clinical proof of concept trial, unless GSK elects to exercise its option earlier. Cellzome is eligible to receive success-based milestones from GSK as product candidates are advanced. Upon Cellzome's achievement of clinical proof of concept for a product candidate for a particular kinase target, GSK would have an exclusive option to license all product candidates from that program. GSK would then assume full responsibility for further clinical development and commercialization on a worldwide basis. Ce
'/>"/>

SOURCE Cellzome Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
2. GlaxoSmithKline To Post Quarterly US Grants Report
3. GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
4. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
5. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
6. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
7. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
8. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
9. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
10. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
11. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...eak at Economic Club of Canada , ...-- Ambassador to Speak at Economic Club of Canada.... International Investment, and Chairman and CEO of...of David Appia go to www.investinfrance.org . , ...th press to discuss recent pro-business initiative...
(Date:11/25/2009)...RNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a ...ced today that it executed,a joint venture (JV) ag...nology Co., Ltd. (Sinovac Dalian). The JV will res...e vaccines. Sinovac will contribute its expertise,...orld-class vaccines; the,other party will bring it...
(Date:11/24/2009)... , Whether it,s CD packaging, containers or i...entification) are increasingly finding their way i...objects or goods and identify them automatically b...d and process the data contained in the label. Sma... conditions of up to 100 degrees Celsius. But at h...
(Date:11/24/2009)...estment bank KTA Capital,s client Neuren Pharmaceu...ertible note private placement with a U.S. institu...d by KTA Capital as Neuren,s exclusive placement a...ork (PRWEB) November 23, 2009 -- The independent N...A Capital") has announced that its client Neu...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...a, Sept. 19 /Xinhua-PRNewswire-FirstCall/ -- China... "the Company") (Nasdaq: CSKI ), a,leading fully ...he-counter,drugs in the People,s Republic of China... completed the first phase of examinations for the...ark, which indicates that,a company,s products hav...
...ustria, September 19 Thirty seven medical,experts...n the medical,community to take urgent action to o...vere mental illness such as schizophrenia or bipol...ker, principal author of Comorbid,Somatic Illnesse...al,Policy, and Research Challenges which was publi...
...Minn., Sept. 18 MedNet Solutions, a global,eClini...udy management,systems, today announced the compan...hibitor at the 2008 Society of Clinical Data Manag... September 21 through,Wednesday, September 24 in D...ratt, PhD, Chief Marketing Officer,and Principal S...
Other Biology Technology:China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification 2China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification 3Global Psychiatrists Unite to Improve Services in Mental Health 2Global Psychiatrists Unite to Improve Services in Mental Health 3MedNet Solutions to Speak, Sponsor and Exhibit at the 2008 Society of Clinical Data Management Annual Conference in Dallas 2
(Date:11/26/2009)...mber 26, 2009) Whitehead researchers have develop... pinpoint specific genes and proteins used by path...In most human cell cultures genes are present in t...rom the mother. Gene inactivation by mutation is t...tivated, the second copy usually remains active an...
(Date:11/25/2009)...duced in the stomach, may be used to boost resista...sease, Yale School of Medicine researchers report ...rnal of Neuroscience . , Parkinson,s disease is ... area of the midbrain known as the substantia nigr...Reduced production of dopamine in late-stage Parki...
(Date:11/25/2009)...25, 2009 Soil is the linchpin of the environment,.... Despite that, many students see soil as "just di...l science educators are challenged with the task o...itical importance of soil in the environment. , ... science teachers at University of Nebraska-Lincol...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Xanodyne Expands U S Sales Force and Launches Zipsor 28TM 29 28diclofenac potassium 29 Liquid Filled Capsules 6235 1Xanodyne Expands U S Sales Force and Launches Zipsor 28TM 29 28diclofenac potassium 29 Liquid Filled Capsules 6235 2Vivakor Presents at Nutraceutical Event 61275 1Vivakor Presents at Nutraceutical Event 61275 2Vivakor Presents at Nutraceutical Event 61275 3Vivakor Presents at Nutraceutical Event 61275 4Vivakor Presents at Nutraceutical Event 61275 5Vivakor Presents at Nutraceutical Event 61275 6AMICAS PACS For Mammography at RSNA 2009 61273 1AMICAS PACS For Mammography at RSNA 2009 61273 2AMICAS PACS For Mammography at RSNA 2009 61273 3
... Children who were allergic to eggs were able to e...suming increased quantities of eggs over time, res... University of Arkansas for Medical Sciences have ... took a daily dose of egg product over the two-yea...resistance to the point where most of them could e...
... As the world,s first explorers branched away from...years ago, distinct mutations accumulated in the D...etic trail for modern researchers to follow. , Rec...s classic genetic system to study ancient migratio...ople or animals as they existed tens of thousands ...
... Walking is a popular form of exercise, but may no...its, a University of Alberta study shows. , "Gener... is not likely going to give anybody marked health...levate the intensity," said Dr. Vicki Harber, lead...nted recently at the American College of Sports Me...
Other Biology News:Pilot study successful in taming allergic reactions to food 2Pilot study successful in taming allergic reactions to food 3History-hunting geneticists can still follow familiar trail 2History-hunting geneticists can still follow familiar trail 3Walking not enough for significant exercise benefits 2
...taneous dual parameter assay for mitochondrial mem...y. Active caspases are detected by carboxyfluoresc...e inhibitors, which are cell-permeable, non-cytoto...hin the cells. At the same time the mitochondrial ...
...L-4 cells were cultured in DMEM and harvested at t...gens in their native forms, cells were fixed in ac...l (5 mm) adhesive coated slide, with each wells su...achment and to minimize background staining. Each...
...yControl™ vector can be induced prior to DNA p...rovide the stability of single-copy BACs with the ...ng vectors. The kits provide the linearized vector...t size screening system) necessary to create a 10X...
...yControl™ vector can be induced prior to DNA p...rovide the stability of single-copy BACs with the ...ng vectors. The kits provide the linearized vector...t size screening system) necessary to create a 10X...
Biology Products: